Atlas Trials

A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy

Clinical trial NCT04036019 · COMPLETED

Trial details

NCT number
NCT04036019
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
B Cell Lymphoma
Start date
2019-08-20
Primary completion
2022-06-20
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.